Go Pro

SNDL (SNDL) Competitors

SNDL logo
$1.31 0.00 (0.00%)
Closing price 07/13/2026 04:00 PM Eastern
Extended Trading
$1.31 0.00 (0.00%)
As of 07/13/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

SNDL vs. ACB, CGC, CRON, GRWG, and OGI

Should you buy SNDL stock or one of its competitors? MarketBeat compares SNDL with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with SNDL include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), GrowGeneration (GRWG), and Organigram Global (OGI).

How does SNDL compare to Aurora Cannabis?

SNDL (NASDAQ:SNDL) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability, media sentiment and earnings.

SNDL has a net margin of -1.19% compared to Aurora Cannabis' net margin of -33.57%. Aurora Cannabis' return on equity of 0.10% beat SNDL's return on equity.

Company Net Margins Return on Equity Return on Assets
SNDL-1.19% -1.02% -0.85%
Aurora Cannabis -33.57%0.10%0.07%

SNDL has higher revenue and earnings than Aurora Cannabis. SNDL is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SNDL$677.32M0.50-$11.29M-$0.03N/A
Aurora Cannabis$247.82M0.66-$88.13M-$1.56N/A

47.6% of Aurora Cannabis shares are owned by institutional investors. 0.0% of Aurora Cannabis shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

SNDL has a beta of 0.92, suggesting that its share price is 8% less volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.57, suggesting that its share price is 43% less volatile than the broader market.

SNDL currently has a consensus target price of $5.00, suggesting a potential upside of 281.68%. Given SNDL's higher possible upside, analysts clearly believe SNDL is more favorable than Aurora Cannabis.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SNDL
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Aurora Cannabis
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, Aurora Cannabis had 5 more articles in the media than SNDL. MarketBeat recorded 6 mentions for Aurora Cannabis and 1 mentions for SNDL. SNDL's average media sentiment score of 1.87 beat Aurora Cannabis' score of 0.24 indicating that SNDL is being referred to more favorably in the media.

Company Overall Sentiment
SNDL Very Positive
Aurora Cannabis Neutral

Summary

SNDL and Aurora Cannabis tied by winning 7 of the 14 factors compared between the two stocks.

How does SNDL compare to Canopy Growth?

Canopy Growth (NASDAQ:CGC) and SNDL (NASDAQ:SNDL) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, profitability, analyst recommendations, institutional ownership, valuation and dividends.

SNDL has a net margin of -1.19% compared to Canopy Growth's net margin of -75.27%. SNDL's return on equity of -1.02% beat Canopy Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Canopy Growth-75.27% -26.95% -17.20%
SNDL -1.19%-1.02%-0.85%

SNDL has a consensus target price of $5.00, indicating a potential upside of 281.68%. Given SNDL's higher possible upside, analysts plainly believe SNDL is more favorable than Canopy Growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Canopy Growth
1 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.17
SNDL
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

3.3% of Canopy Growth shares are owned by institutional investors. 0.2% of Canopy Growth shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Canopy Growth has a beta of 0.79, indicating that its share price is 21% less volatile than the broader market. Comparatively, SNDL has a beta of 0.92, indicating that its share price is 8% less volatile than the broader market.

SNDL has higher revenue and earnings than Canopy Growth. SNDL is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Canopy Growth$251.01M1.72-$190.29M-$0.59N/A
SNDL$677.32M0.50-$11.29M-$0.03N/A

In the previous week, Canopy Growth had 6 more articles in the media than SNDL. MarketBeat recorded 7 mentions for Canopy Growth and 1 mentions for SNDL. SNDL's average media sentiment score of 1.87 beat Canopy Growth's score of 1.10 indicating that SNDL is being referred to more favorably in the news media.

Company Overall Sentiment
Canopy Growth Positive
SNDL Very Positive

Summary

SNDL beats Canopy Growth on 9 of the 16 factors compared between the two stocks.

How does SNDL compare to Cronos Group?

SNDL (NASDAQ:SNDL) and Cronos Group (NASDAQ:CRON) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, valuation, dividends, profitability and analyst recommendations.

8.7% of Cronos Group shares are owned by institutional investors. 7.8% of Cronos Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Cronos Group has lower revenue, but higher earnings than SNDL. SNDL is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SNDL$677.32M0.50-$11.29M-$0.03N/A
Cronos Group$146.59M7.00-$9.45M$0.01275.00

In the previous week, SNDL and SNDL both had 1 articles in the media. SNDL's average media sentiment score of 1.87 beat Cronos Group's score of 0.96 indicating that SNDL is being referred to more favorably in the media.

Company Overall Sentiment
SNDL Very Positive
Cronos Group Positive

SNDL has a beta of 0.92, meaning that its stock price is 8% less volatile than the broader market. Comparatively, Cronos Group has a beta of 0.89, meaning that its stock price is 11% less volatile than the broader market.

SNDL presently has a consensus price target of $5.00, indicating a potential upside of 281.68%. Cronos Group has a consensus price target of $2.30, indicating a potential downside of 16.36%. Given SNDL's higher probable upside, equities analysts plainly believe SNDL is more favorable than Cronos Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SNDL
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Cronos Group
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20

Cronos Group has a net margin of -1.14% compared to SNDL's net margin of -1.19%. SNDL's return on equity of -1.02% beat Cronos Group's return on equity.

Company Net Margins Return on Equity Return on Assets
SNDL-1.19% -1.02% -0.85%
Cronos Group -1.14%-1.26%-1.20%

Summary

Cronos Group beats SNDL on 9 of the 15 factors compared between the two stocks.

How does SNDL compare to GrowGeneration?

SNDL (NASDAQ:SNDL) and GrowGeneration (NASDAQ:GRWG) are related small-cap companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, dividends, earnings, institutional ownership, risk, profitability, valuation and analyst recommendations.

In the previous week, GrowGeneration had 2 more articles in the media than SNDL. MarketBeat recorded 3 mentions for GrowGeneration and 1 mentions for SNDL. SNDL's average media sentiment score of 1.87 beat GrowGeneration's score of 0.53 indicating that SNDL is being referred to more favorably in the media.

Company Overall Sentiment
SNDL Very Positive
GrowGeneration Positive

SNDL has a net margin of -1.19% compared to GrowGeneration's net margin of -11.91%. SNDL's return on equity of -1.02% beat GrowGeneration's return on equity.

Company Net Margins Return on Equity Return on Assets
SNDL-1.19% -1.02% -0.85%
GrowGeneration -11.91%-19.50%-12.91%

SNDL has a beta of 0.92, meaning that its share price is 8% less volatile than the broader market. Comparatively, GrowGeneration has a beta of 2.5, meaning that its share price is 150% more volatile than the broader market.

SNDL currently has a consensus target price of $5.00, indicating a potential upside of 281.68%. Given SNDL's stronger consensus rating and higher possible upside, equities analysts clearly believe SNDL is more favorable than GrowGeneration.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SNDL
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
GrowGeneration
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67

36.0% of GrowGeneration shares are owned by institutional investors. 8.1% of GrowGeneration shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

SNDL has higher revenue and earnings than GrowGeneration. SNDL is trading at a lower price-to-earnings ratio than GrowGeneration, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SNDL$677.32M0.50-$11.29M-$0.03N/A
GrowGeneration$161.74M0.54-$24.05M-$0.32N/A

Summary

SNDL beats GrowGeneration on 10 of the 16 factors compared between the two stocks.

How does SNDL compare to Organigram Global?

SNDL (NASDAQ:SNDL) and Organigram Global (NASDAQ:OGI) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, profitability, dividends and analyst recommendations.

In the previous week, SNDL and SNDL both had 1 articles in the media. Organigram Global's average media sentiment score of 1.89 beat SNDL's score of 1.87 indicating that Organigram Global is being referred to more favorably in the news media.

Company Overall Sentiment
SNDL Very Positive
Organigram Global Very Positive

34.6% of Organigram Global shares are owned by institutional investors. 0.1% of Organigram Global shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

SNDL presently has a consensus price target of $5.00, indicating a potential upside of 281.68%. Given SNDL's higher possible upside, equities research analysts plainly believe SNDL is more favorable than Organigram Global.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SNDL
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Organigram Global
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

SNDL has a net margin of -1.19% compared to Organigram Global's net margin of -9.22%. SNDL's return on equity of -1.02% beat Organigram Global's return on equity.

Company Net Margins Return on Equity Return on Assets
SNDL-1.19% -1.02% -0.85%
Organigram Global -9.22%-13.41%-9.09%

SNDL has a beta of 0.92, meaning that its share price is 8% less volatile than the broader market. Comparatively, Organigram Global has a beta of 1.45, meaning that its share price is 45% more volatile than the broader market.

SNDL has higher revenue and earnings than Organigram Global. SNDL is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SNDL$677.32M0.50-$11.29M-$0.03N/A
Organigram Global$185.07M0.68-$17.70M-$0.13N/A

Summary

Organigram Global beats SNDL on 8 of the 15 factors compared between the two stocks.

Get SNDL News Delivered to You Automatically

Sign up to receive the latest news and ratings for SNDL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SNDL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SNDL vs. The Competition

MetricSNDLMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$337.19M$8.82B$7.05B$12.61B
Dividend YieldN/A2.54%2.68%8.00%
P/E Ratio-43.6716.0927.1124.26
Price / Sales0.507.04587.92117.88
Price / Cash11.6318.4029.2249.36
Price / Book0.433.5710.756.29
Net Income-$11.29M$228.19M$3.58B$330.66M
7 Day Performance0.77%-2.31%-2.06%-1.32%
1 Month Performance-7.75%-0.62%3.32%-0.64%
1 Year Performance-17.09%-2.73%26.35%19.08%

SNDL Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SNDL
SNDL
4.2232 of 5 stars
$1.31
flat
$5.00
+281.7%
-5.8%$337.19M$677.32MN/A2,751
ACB
Aurora Cannabis
1.3295 of 5 stars
$2.71
-4.6%
N/A-40.5%$174.22M$247.82MN/A1,028
CGC
Canopy Growth
1.3239 of 5 stars
$0.96
-4.0%
N/A-15.0%$448.42M$251.01MN/A1,128
CRON
Cronos Group
1.6134 of 5 stars
$2.76
-3.5%
$2.30
-16.7%
+31.6%$1.07B$146.59M276.28450
GRWG
GrowGeneration
2.4567 of 5 stars
$1.49
+1.4%
N/A+39.4%$88.33M$161.74MN/A690

Related Companies and Tools


This page (NASDAQ:SNDL) was last updated on 7/14/2026 by MarketBeat.com Staff.
From Our Partners